184 related articles for article (PubMed ID: 37261631)
1. Beijing Children's Hospital guidelines on the design and conduction of the first standardized database for medulloblastoma.
Yang W; Ma W; Huang J; Cai Y; Peng X; Zhao F; Zhang D; Zou Z; Sun H; Qi X; Ge M
Metab Brain Dis; 2023 Oct; 38(7):2393-2400. PubMed ID: 37261631
[TBL] [Abstract][Full Text] [Related]
2. Medulloblastoma: presentation, diagnosis and management.
Packer RJ; Finlay JL
Oncology (Williston Park); 1988 Sep; 2(9):35-45, 48-9. PubMed ID: 3275066
[TBL] [Abstract][Full Text] [Related]
3. Review of the prognostic factors in medulloblastoma of children and adults.
Brandes AA; Paris MK
Crit Rev Oncol Hematol; 2004 May; 50(2):121-8. PubMed ID: 15157661
[TBL] [Abstract][Full Text] [Related]
4. Updates on Management of Adult Medulloblastoma.
Majd N; Penas-Prado M
Curr Treat Options Oncol; 2019 Jun; 20(8):64. PubMed ID: 31236711
[TBL] [Abstract][Full Text] [Related]
5. Outcome for children treated for medulloblastoma and supratentorial primitive neuroectodermal tumor (CNS-PNET) - a retrospective analysis spanning 40 years of treatment.
Stensvold E; Krossnes BK; Lundar T; Due-Tønnessen BJ; Frič R; Due-Tønnessen P; Bechensteen AG; Myklebust TÅ; Johannesen TB; Brandal P
Acta Oncol; 2017 May; 56(5):698-705. PubMed ID: 28325133
[TBL] [Abstract][Full Text] [Related]
6. Nevoid basal cell carcinoma syndrome: relation with desmoplastic medulloblastoma in infancy. A population-based study and review of the literature.
Amlashi SF; Riffaud L; Brassier G; Morandi X
Cancer; 2003 Aug; 98(3):618-24. PubMed ID: 12879481
[TBL] [Abstract][Full Text] [Related]
7. Salvage therapy for progressive, treatment-refractory or recurrent pediatric medulloblastoma: a systematic review protocol.
Adile AA; Kameda-Smith MM; Bakhshinyan D; Banfield L; Salim SK; Farrokhyar F; Fleming AJ
Syst Rev; 2020 Mar; 9(1):47. PubMed ID: 32127049
[TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid cytokines in metastatic group 3 and 4 medulloblastoma.
Low SYY; Bte Syed Sulaiman N; Tan EEK; Ng LP; Kuick CH; Chang KTE; Tang PH; Wong RX; Looi WS; Low DCY; Seow WT
BMC Cancer; 2020 Jun; 20(1):554. PubMed ID: 32539808
[TBL] [Abstract][Full Text] [Related]
9. Childhood Medulloblastoma: An Overview.
Suk Y; Gwynne WD; Burns I; Venugopal C; Singh SK
Methods Mol Biol; 2022; 2423():1-12. PubMed ID: 34978683
[TBL] [Abstract][Full Text] [Related]
10. [Medulloblastoma].
Bouffet E; Frappaz D; Carrie C; Freycon F; Brunat-Mentigny M
Pediatrie; 1991; 46(1):71-8. PubMed ID: 1851287
[TBL] [Abstract][Full Text] [Related]
11. Childhood medulloblastoma: progress and future challenges.
Packer RJ
Brain Dev; 1999 Mar; 21(2):75-81. PubMed ID: 10206522
[TBL] [Abstract][Full Text] [Related]
12. Classic and desmoplastic medulloblastoma: complete case reports and characterizations of two new cell lines.
Holthouse DJ; Dallas PB; Ford J; Fabian V; Murch AR; Watson M; Wong G; Bertram C; Egli S; Baker DL; Kees UR
Neuropathology; 2009 Aug; 29(4):398-409. PubMed ID: 19077040
[TBL] [Abstract][Full Text] [Related]
13. Prognostic effect of whole chromosomal aberration signatures in standard-risk, non-WNT/non-SHH medulloblastoma: a retrospective, molecular analysis of the HIT-SIOP PNET 4 trial.
Goschzik T; Schwalbe EC; Hicks D; Smith A; Zur Muehlen A; Figarella-Branger D; Doz F; Rutkowski S; Lannering B; Pietsch T; Clifford SC
Lancet Oncol; 2018 Dec; 19(12):1602-1616. PubMed ID: 30392813
[TBL] [Abstract][Full Text] [Related]
14. Understanding medulloblastoma.
Quinlan A; Rizzolo D
JAAPA; 2017 Oct; 30(10):30-36. PubMed ID: 28953021
[TBL] [Abstract][Full Text] [Related]
15. The clinical treatment and outcome of cerebellopontine angle medulloblastoma: a retrospective study of 15 cases.
Wu T; Qu PR; Zhang S; Li SW; Zhang J; Wang B; Liu P; Li CD; Zhao F
Sci Rep; 2020 Jun; 10(1):9769. PubMed ID: 32555264
[TBL] [Abstract][Full Text] [Related]
16. Histologic Correlates of Molecular Group 4 Pediatric Medulloblastoma: A Retrospective Canadian Review.
Triscott J; Yip S; Johnston D; Michaud J; Rassekh SR; Hukin J; Dunn S; Dunham C
Pediatr Dev Pathol; 2021; 24(4):309-317. PubMed ID: 33749384
[TBL] [Abstract][Full Text] [Related]
17. Medulloblastoma: what is the role of molecular genetics?
Entz-Werle N; Carli ED; Ducassou S; Legrain M; Grill J; Dufour C
Expert Rev Anticancer Ther; 2008 Jul; 8(7):1169-81. PubMed ID: 18588461
[TBL] [Abstract][Full Text] [Related]
18. Young investigator challenge: Cytomorphologic analysis of cerebrospinal fluid in 70 pediatric patients with medulloblastoma and review of the literature focusing on novel diagnostic and prognostic tests.
Damiani D; Suciu V; Andreiuolo F; Calderaro J; Vielh P
Cancer Cytopathol; 2015 Nov; 123(11):644-9. PubMed ID: 26769585
[TBL] [Abstract][Full Text] [Related]
19. Medulloblastoma in China: clinicopathologic analyses of SHH, WNT, and non-SHH/WNT molecular subgroups reveal different therapeutic responses to adjuvant chemotherapy.
Zhang ZY; Xu J; Ren Y; Li KK; Ng HK; Mao Y; Zhong P; Yao Y; Zhou LF
PLoS One; 2014; 9(6):e99490. PubMed ID: 24932704
[TBL] [Abstract][Full Text] [Related]
20. Current multimodality management of medulloblastoma.
Paulino AC
Curr Probl Cancer; 2002; 26(6):317-56. PubMed ID: 12447347
[No Abstract] [Full Text] [Related]
[Next] [New Search]
